These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31075076)

  • 1. Decoding the link between WWOX and p53 in aggressive breast cancer.
    Abdeen SK; Aqeilan RI
    Cell Cycle; 2019 Jun; 18(11):1177-1186. PubMed ID: 31075076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer.
    Abdeen SK; Ben-David U; Shweiki A; Maly B; Aqeilan RI
    Cell Death Dis; 2018 Aug; 9(8):832. PubMed ID: 30082886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
    Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
    Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs.
    Khawaled S; Suh SS; Abdeen SK; Monin J; Distefano R; Nigita G; Croce CM; Aqeilan RI
    Cancer Res; 2019 Apr; 79(8):1784-1798. PubMed ID: 30622118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic tumor suppressor functions of WWOX antagonize metastasis.
    Khawaled S; Nigita G; Distefano R; Oster S; Suh SS; Smith Y; Khalaileh A; Peng Y; Croce CM; Geiger T; Seewaldt VL; Aqeilan RI
    Signal Transduct Target Ther; 2020 Apr; 5(1):43. PubMed ID: 32300104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism.
    Chou PY; Lin SR; Lee MH; Schultz L; Sze CI; Chang NS
    Cell Commun Signal; 2019 Jul; 17(1):76. PubMed ID: 31315632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
    Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
    Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WW domain-containing oxidoreductase: a candidate tumor suppressor.
    Chang NS; Hsu LJ; Lin YS; Lai FJ; Sheu HM
    Trends Mol Med; 2007 Jan; 13(1):12-22. PubMed ID: 17142102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.
    Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW
    Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype.
    Wang X; Chao L; Ma G; Chen L; Zang Y; Sun J
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):271-8. PubMed ID: 20401669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.
    Liu SY; Chiang MF; Chen YJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):315-23. PubMed ID: 25432984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell signaling and apoptosis by tumor suppressor WWOX.
    Lo JY; Chou YT; Lai FJ; Hsu LJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):383-91. PubMed ID: 25595191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The downregulation of WWOX induces epithelial-mesenchymal transition and enhances stemness and chemoresistance in breast cancer.
    Li J; Liu J; Li P; Zhou C; Liu P
    Exp Biol Med (Maywood); 2018 Sep; 243(13):1066-1073. PubMed ID: 30335523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-negative breast cancer: disease entity or title of convenience?
    Carey L; Winer E; Viale G; Cameron D; Gianni L
    Nat Rev Clin Oncol; 2010 Dec; 7(12):683-92. PubMed ID: 20877296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis.
    Chang R; Song L; Xu Y; Wu Y; Dai C; Wang X; Sun X; Hou Y; Li W; Zhan X; Zhan L
    Nat Commun; 2018 Aug; 9(1):3486. PubMed ID: 30154439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
    Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
    Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
    Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
    Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.